The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?
0
Patients who cannot afford Wegovy or have struggled to find it have been turning to often-cheaper compounded versions sold by pharmacies.
More than 200,000 prescriptions for copies of Novo Nordisk’s weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter, saying it should consider their role in alleviating the obesity drug supply crunch before barring them.